ATE477329T1 - Verfahren zur detektion der in-vivo-aktivität von neurotrypsin, verwendung des verfahrens und verwendung des c-terminal 22-kda-fragments als biomarker bei der diagnose und überwachung von störungen im zusammenhang mit neurotrypsin - Google Patents
Verfahren zur detektion der in-vivo-aktivität von neurotrypsin, verwendung des verfahrens und verwendung des c-terminal 22-kda-fragments als biomarker bei der diagnose und überwachung von störungen im zusammenhang mit neurotrypsinInfo
- Publication number
- ATE477329T1 ATE477329T1 AT07009398T AT07009398T ATE477329T1 AT E477329 T1 ATE477329 T1 AT E477329T1 AT 07009398 T AT07009398 T AT 07009398T AT 07009398 T AT07009398 T AT 07009398T AT E477329 T1 ATE477329 T1 AT E477329T1
- Authority
- AT
- Austria
- Prior art keywords
- neurotrypsin
- biomarker
- diagnosing
- detecting
- terminal
- Prior art date
Links
- 102100035484 Neurotrypsin Human genes 0.000 title abstract 6
- 108010037733 neurotrypsin Proteins 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 4
- 239000000090 biomarker Substances 0.000 title abstract 2
- 238000012544 monitoring process Methods 0.000 title abstract 2
- 101150079978 AGRN gene Proteins 0.000 abstract 3
- 102100040026 Agrin Human genes 0.000 abstract 3
- 108700019743 Agrin Proteins 0.000 abstract 3
- 239000012634 fragment Substances 0.000 abstract 3
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07009398A EP1990420B1 (de) | 2007-05-10 | 2007-05-10 | Verfahren zur Detektion der in-vivo-Aktivität von Neurotrypsin, Verwendung des Verfahrens und Verwendung des C-terminal 22-kDa-Fragments als Biomarker bei der Diagnose und Überwachung von Störungen im Zusammenhang mit Neurotrypsin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE477329T1 true ATE477329T1 (de) | 2010-08-15 |
Family
ID=38180345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07009398T ATE477329T1 (de) | 2007-05-10 | 2007-05-10 | Verfahren zur detektion der in-vivo-aktivität von neurotrypsin, verwendung des verfahrens und verwendung des c-terminal 22-kda-fragments als biomarker bei der diagnose und überwachung von störungen im zusammenhang mit neurotrypsin |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20100240083A1 (de) |
| EP (1) | EP1990420B1 (de) |
| JP (1) | JP2010526994A (de) |
| CN (1) | CN101680022A (de) |
| AT (1) | ATE477329T1 (de) |
| AU (1) | AU2008250733A1 (de) |
| BR (1) | BRPI0811429A2 (de) |
| CA (1) | CA2692132A1 (de) |
| CY (1) | CY1111602T1 (de) |
| DE (1) | DE602007008370D1 (de) |
| DK (1) | DK1990420T3 (de) |
| ES (1) | ES2350254T3 (de) |
| PL (1) | PL1990420T3 (de) |
| PT (1) | PT1990420E (de) |
| SI (1) | SI1990420T1 (de) |
| WO (1) | WO2008138474A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2484695A1 (de) | 2011-02-04 | 2012-08-08 | Neurotune AG | Verfahren zur Herstellung von Hybridoma-Zelllinien zur Erzeugung monoklonaler Antikörper zur spezifischen Bindung an ein humanes C44-Fragment von Agrin |
| EP2631657A1 (de) | 2012-02-25 | 2013-08-28 | Neurotune AG | Immunoassay zur Detektion des 22kDa-C-terminalen-Fragments (CAF) von Agrin |
| US20160274126A1 (en) * | 2012-11-13 | 2016-09-22 | William Beaumont Hospital | Biomarkers for the diagnosis of interstitial cystitis |
| CN111727038B (zh) * | 2018-01-17 | 2025-05-13 | 南安普顿大学 | 肌肉减少症和nad缺乏的风险预测及分级方法 |
| US11564983B1 (en) * | 2021-08-20 | 2023-01-31 | Betagen Scientific Limited | Efficient expression system of SARS-CoV-2 receptor binding domain (RBD), methods for purification and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1868989A2 (de) * | 2005-03-30 | 2007-12-26 | University of Zurich | Inhibitoren von neurotrypsin und deren bestimmung |
| US20100095387A1 (en) * | 2005-07-15 | 2010-04-15 | Martin Smith | Methods and reagents for screening new drugs and for treating ion pump associated disorders and diseases |
-
2007
- 2007-05-10 AT AT07009398T patent/ATE477329T1/de active
- 2007-05-10 SI SI200730401T patent/SI1990420T1/sl unknown
- 2007-05-10 PT PT07009398T patent/PT1990420E/pt unknown
- 2007-05-10 PL PL07009398T patent/PL1990420T3/pl unknown
- 2007-05-10 DE DE602007008370T patent/DE602007008370D1/de active Active
- 2007-05-10 EP EP07009398A patent/EP1990420B1/de not_active Not-in-force
- 2007-05-10 DK DK07009398.4T patent/DK1990420T3/da active
- 2007-05-10 ES ES07009398T patent/ES2350254T3/es active Active
-
2008
- 2008-04-26 AU AU2008250733A patent/AU2008250733A1/en not_active Abandoned
- 2008-04-26 WO PCT/EP2008/003406 patent/WO2008138474A1/en not_active Ceased
- 2008-04-26 CN CN200880015511A patent/CN101680022A/zh active Pending
- 2008-04-26 US US12/599,456 patent/US20100240083A1/en not_active Abandoned
- 2008-04-26 JP JP2010506829A patent/JP2010526994A/ja not_active Withdrawn
- 2008-04-26 CA CA002692132A patent/CA2692132A1/en not_active Abandoned
- 2008-04-26 BR BRPI0811429A patent/BRPI0811429A2/pt not_active IP Right Cessation
-
2010
- 2010-11-08 CY CY20101101006T patent/CY1111602T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008138474A1 (en) | 2008-11-20 |
| AU2008250733A1 (en) | 2008-11-20 |
| EP1990420B1 (de) | 2010-08-11 |
| ES2350254T3 (es) | 2011-01-20 |
| US20100240083A1 (en) | 2010-09-23 |
| CA2692132A1 (en) | 2008-11-20 |
| SI1990420T1 (sl) | 2010-12-31 |
| BRPI0811429A2 (pt) | 2016-05-17 |
| DK1990420T3 (da) | 2010-11-15 |
| PT1990420E (pt) | 2010-11-04 |
| PL1990420T3 (pl) | 2011-01-31 |
| JP2010526994A (ja) | 2010-08-05 |
| CY1111602T1 (el) | 2015-10-07 |
| EP1990420A1 (de) | 2008-11-12 |
| CN101680022A (zh) | 2010-03-24 |
| DE602007008370D1 (de) | 2010-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006014535D1 (de) | Verwendung von nt-proanp und nt-probnp zur diagnose von herzerkrankungen | |
| GB2488700B (en) | Methods for monitoring disease conditions by analysis of the full repertoire of CDR3 sequences of an individual | |
| ATE533061T1 (de) | Verfahren zur diagnose bakterieller infektionen | |
| ATE537454T1 (de) | Verfahren zum beurteilen von herzinsuffizienz bei patienten mit vorhofflimmern mittels gdf-15 | |
| EP4219759A3 (de) | Überwachung des gesundheits- und krankheitszustands unter verwendung von klonotypprofilen | |
| WO2014066913A3 (en) | Health diagnostic systems and methods | |
| JP2012529655A5 (de) | ||
| ATE554389T1 (de) | Apex als marker für lungenkrebs | |
| DE602006011896D1 (de) | Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden | |
| DE10345171A1 (de) | Überwachungssystem für Patienten | |
| ATE523777T1 (de) | System und verfahren zur bestimmung der analytkonzentration mittels zeitaufgelöster amperometrie | |
| DE602007008370D1 (de) | Verfahren zur Detektion der in-vivo-Aktivität von Neurotrypsin, Verwendung des Verfahrens und Verwendung des C-terminal 22-kDa-Fragments als Biomarker bei der Diagnose und Überwachung von Störungen im Zusammenhang mit Neurotrypsin | |
| DE602008006649D1 (de) | Blutdruckberechnungsverfahren für nichtinvasive Blutdruckmessgeräte | |
| ATE548467T1 (de) | Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände | |
| WO2009047283A3 (en) | Means and methods for monitoring myocardial infarction and its treatment | |
| WO2008132464A3 (en) | Mek5 and related proteins as biomarkers of neurodegenerative diseases | |
| NZ592819A (en) | Thyroid analyte detection and measurement | |
| ATE518139T1 (de) | Verfahren zur diagnose einer krankheit mit beteiligung eines anti-at1-rezeptor-antikörpers | |
| ATE354097T1 (de) | Verfahren zur diagnose von leberfibrose. | |
| ATE468535T1 (de) | Verwendung von nnmt als marker für lungenkrebs | |
| WO2009111671A3 (en) | System including method and device for identification and monitoring of pulmonary data | |
| ATE550668T1 (de) | Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis | |
| DE502006008028D1 (de) | Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen | |
| ATE529745T1 (de) | Verfahren zur bewertung des hautempfindlichkeitsniveaus durch verwendung von mit plattenepithelkarzinom zusammenhängendem antigen als indikation | |
| ATE534037T1 (de) | Verwendung des proteins asc als marker für brustkrebs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1990420 Country of ref document: EP |